BioVie Inc. ( BIVI) - Key Metrics
BIVI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0 | -$0.75 | -$0.55 | -$0.55 |
| 2026Q3 | $0 | -$0.70 | -$0.99 | -$0.99 |
| 2026Q2 | $0 | -$0.77 | -$0.56 | -$0.56 |
| 2026Q1 | $0 | -$0.98 | -$0.58 | -$0.58 |
| 2025Q4 | $0 | -$0.24 | -$0.38 | -$0.38 |
BIVI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -0.65 |
| 2026Q3 | 0% | -0.50 |
| 2026Q2 | 0% | -0.38 |
| 2026Q1 | 0% | -0.48 |
| 2025Q4 | 0% | -9.64 |
BIVI
Price: $1.33
52 week price:
Earnings Per Share: -3.05 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 123600
Market Capitalization: 11.0 million